CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Asmabec Clickhaler

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 16 USDMF, 12 CEP/COS, 2 JDMF, 9 EU WC, 2 KDMF, 15 NDC API, 38 Listed Suppliers

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

FINISHED DOSAGE FORMULATIONS

393 FDF Dossiers, 16 FDA Orange Book, 302 Europe, 7 Canada, 18 Australia, 15 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 15 Thickeners and Stabilizers, 15 Solubilizers, 9 Parenteral, 9 Direct Compression, 8 Co-Processed Excipients, 5 Controlled & Modified Release, 5 Disintegrants & Superdisintegrants, 5 Granulation, 4 Chewable & Orodispersible Aids, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 4 Rheology Modifiers, 3 Emulsifying Agents, 3 Taste Masking, 3 Surfactant & Foaming Agents, 3 Topical, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 22 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 60 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

14 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

44 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

Xls

Filters

Supplier	Contact Email	Supplier's Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
Symbiotec Pharmalab	symbiotec@symbiotec.in	https://www.pharmacompass.com/pharma-services/api-fdf-drug-development/symbiotec-pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LTD	28137	BECLOMETHASONE DIPROPIONATE USP (MICRONIZED & NON-MICRONIZED)	2014-03-20	Active	II	N/A
Axplora	axplora@axplora.com	https://www.pharmacompass.com/pharma-services/api-fdf-drug-development/axplora-farmabios-pharmazell-and-novasep	Germany	FARMABIOS SPA	12813	BECLOMETHASONE DIPROPIONATE	1998-01-05	Active	II	Complete	2019-04-25	2019-04-22

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Asmabec Clickhaler

Asmabec Clickhaler

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

63 API Suppliers

16 USDMF

12 CEP/COS

2 JDMF

9 EU WC

2 KDMF

15 NDC API

38 Listed Suppliers

DEVELOPMENTS

63 Drugs in Development

FINISHED DOSAGE FORMULATIONS

393 FDF Dossiers

16 FDA Orange Book

302 Europe

7 Canada

18 Australia

15 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Kirsch Pharma

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

2 Kerry

2 Keval Exports

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 Silverline Chemicals

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

15 Thickeners and Stabilizers

15 Solubilizers

9 Parenteral

9 Direct Compression

8 Co-Processed Excipients

5 Controlled & Modified Release

5 Disintegrants & Superdisintegrants

5 Granulation

4 Chewable & Orodispersible Aids

4 Coating Systems & Additives

4 Film Formers & Plasticizers

4 Rheology Modifiers

3 Emulsifying Agents

3 Taste Masking

3 Surfactant & Foaming Agents

3 Topical

1 Lubricants & Glidants

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons